Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Jilg

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|July 26, 2011
Adding to the toolbox: receptor tyrosine kinases as potential targets in the treatment of hepatitis CNikolaus Jilg, Raymond T Chung
Hepatology (Baltimore, Md.)|August 23, 2012
One more piece in the interleukin 28B gene puzzle? The case of hepatitis BNikolaus Jilg, Raymond T Chung
Hepatology (Baltimore, Md.)|April 10, 2023
Unfolding the mechanism of hepatocyte injury of HBV precore and core promoter variantsNikolaus Jilg, Thomas F Baumert
Infectious Disease Clinics of North America|August 10, 2019
On the Road to a HIV Cure: Moving Beyond Berlin and LondonNikolaus Jilg, Jonathan Z Li
AIDS (London, England)|September 14, 2018
HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort studyNikolaus Jilg, Peter W Hunt, Rajesh T Gandhi
Antiviral Research|February 15, 2014
Entry inhibitors and future treatment of hepatitis CIsabel Fofana, Nikolaus Jilg, Raymond T Chung, et al.
The New England Journal of Medicine|December 28, 2019
Case 40-2019: A 26-Year-Old Returning Traveler with HeadacheGeren S Stone, McKinley Glover, Nikolaus Jilg, et al.
The New England Journal of Medicine|February 3, 2021
A Treacherous CourseJessica Little, Anand Vaidya, Nikolaus Jilg, et al.
Cellular Signalling|October 29, 2002
Involvement of NF-kappaB signalling in skin physiology and diseaseSusanne Bell, Klaus Degitz, Martina Quirling, et al.
The New England Journal of Medicine|March 3, 2021
A Treacherous CourseNikolaus Jilg, Emily S Lau, Meghan A Baker, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|July 26, 2011
Adding to the toolbox: receptor tyrosine kinases as potential targets in the treatment of hepatitis CNikolaus Jilg, Raymond T Chung
Hepatology (Baltimore, Md.)|August 23, 2012
One more piece in the interleukin 28B gene puzzle? The case of hepatitis BNikolaus Jilg, Raymond T Chung
Hepatology (Baltimore, Md.)|April 10, 2023
Unfolding the mechanism of hepatocyte injury of HBV precore and core promoter variantsNikolaus Jilg, Thomas F Baumert
Infectious Disease Clinics of North America|August 10, 2019
On the Road to a HIV Cure: Moving Beyond Berlin and LondonNikolaus Jilg, Jonathan Z Li
AIDS (London, England)|September 14, 2018
HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort studyNikolaus Jilg, Peter W Hunt, Rajesh T Gandhi
Antiviral Research|February 15, 2014
Entry inhibitors and future treatment of hepatitis CIsabel Fofana, Nikolaus Jilg, Raymond T Chung, et al.
The New England Journal of Medicine|December 28, 2019
Case 40-2019: A 26-Year-Old Returning Traveler with HeadacheGeren S Stone, McKinley Glover, Nikolaus Jilg, et al.
The New England Journal of Medicine|February 3, 2021
A Treacherous CourseJessica Little, Anand Vaidya, Nikolaus Jilg, et al.
Cellular Signalling|October 29, 2002
Involvement of NF-kappaB signalling in skin physiology and diseaseSusanne Bell, Klaus Degitz, Martina Quirling, et al.
The New England Journal of Medicine|March 3, 2021
A Treacherous CourseNikolaus Jilg, Emily S Lau, Meghan A Baker, et al.
Pageof 4